Stock Analysis on Net

Intuitive Surgical Inc. (NASDAQ:ISRG)

$24.99

Return on Capital (ROC)

Microsoft Excel

Return on capital (ROC) is after tax rate of return on net business assets. ROIC is unaffected by changes in interest rates or company debt and equity structure. It measures business productivity performance.

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Return on Invested Capital (ROIC)

Intuitive Surgical Inc., ROIC calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data (US$ in thousands)
Net operating profit after taxes (NOPAT)1
Invested capital2
Performance Ratio
ROIC3
Benchmarks
ROIC, Competitors4
Abbott Laboratories
CVS Health Corp.
Elevance Health Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 NOPAT. See details »

2 Invested capital. See details »

3 2024 Calculation
ROIC = 100 × NOPAT ÷ Invested capital
= 100 × ÷ =

4 Click competitor name to see calculations.


The financial data reveals notable fluctuations in key performance metrics over the five-year period under review.

Net Operating Profit After Taxes (NOPAT)

The NOPAT exhibited a variable trajectory. Starting at approximately $1.15 billion in 2020, it increased significantly to around $1.70 billion in 2021. However, there was a decline in 2022, with NOPAT dropping to about $1.19 billion. Subsequently, the profit rebounded to nearly $1.60 billion in 2023, followed by a robust increase reaching approximately $2.24 billion in 2024. This pattern indicates periods of both contraction and expansion in operational profitability, ending with a strong upward movement in the most recent year.

Invested Capital

Invested capital showed a steady and consistent growth across the years. Beginning at roughly $4.49 billion in 2020, it remained relatively stable into 2021. From 2022 onwards, there was a marked increase, rising to approximately $5.40 billion, followed by a substantial jump to $7.16 billion in 2023, and further increasing to about $7.80 billion in 2024. This trend indicates ongoing investment and expansion efforts within the company, with nearly a doubling of invested capital over the five-year span.

Return on Invested Capital (ROIC)

ROIC demonstrated significant volatility during the period. It peaked at 37.63% in 2021 after starting at 25.62% in 2020, reflecting highly efficient use of capital that year. The ratio then sharply declined to 22.01% in 2022 and remained relatively stable at 22.3% in 2023, suggesting a dip in capital efficiency despite increases in invested capital. In 2024, ROIC improved considerably to 28.75%, indicating a recovery in the effectiveness of invested funds in generating returns.

Overall, the data depicts a company undergoing phases of strategic investment and operational adjustments. The initial rise and subsequent fall in ROIC alongside fluctuating NOPAT suggests challenges in maintaining profitability levels commensurate with increasing capital deployment. However, the upward trend in both NOPAT and ROIC in the final year analyzed points to improved operational performance and capital utilization efficiency going forward.


Decomposition of ROIC

Intuitive Surgical Inc., decomposition of ROIC

Microsoft Excel
ROIC = OPM1 × TO2 × 1 – CTR3
Dec 31, 2024 = × ×
Dec 31, 2023 = × ×
Dec 31, 2022 = × ×
Dec 31, 2021 = × ×
Dec 31, 2020 = × ×

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 Operating profit margin (OPM). See calculations »

2 Turnover of capital (TO). See calculations »

3 Effective cash tax rate (CTR). See calculations »


The analysis of the financial metrics over the five-year period reveals varying trends in operational efficiency, capital utilization, tax effects, and overall profitability.

Operating Profit Margin (OPM)
The operating profit margin shows fluctuations with a peak in 2021 at 33.56%, followed by a decline to 26.19% in 2022. It then experiences a recovery trend, increasing to 28.14% in 2023 and further to 32.39% in 2024. This suggests periods of varying operational efficiency, with a general improvement toward the end of the period.
Turnover of Capital (TO)
The turnover of capital ratio increased significantly from 0.98 in 2020 to 1.27 in 2021, indicating a more efficient use of capital assets. Subsequently, it declined to 1.16 in 2022 and further to 1.00 in 2023, before slightly recovering to 1.07 in 2024. This pattern implies that capital utilization was most effective in 2021, followed by a modest reduction in efficiency.
1 – Effective Cash Tax Rate (CTR)
This metric decreased from 93.33% in 2020 to 72.6% in 2022, indicating a rising effective cash tax burden during this period. After 2022, it improved somewhat to 79.06% in 2023 and 82.58% in 2024. Despite these changes, the effective cash tax rate remains at relatively high levels throughout the period, impacting net profitability.
Return on Invested Capital (ROIC)
ROIC shows a peak at 37.63% in 2021, reflecting high returns on capital investments. However, it declines significantly to 22.01% in 2022 and remains relatively steady in 2023 at 22.3%. The return improves again in 2024 to 28.75%, showing a partial recovery but not reaching earlier peak levels. This trend highlights volatility in the company’s ability to generate returns from its invested capital.

In summary, the financial data reveals that 2021 was a peak year in terms of operational margin, capital turnover, and returns on capital, whereas 2022 showed a notable dip across these metrics, alongside an increased effective cash tax burden. The years 2023 and 2024 indicate a recovery phase, with improving operating margins and returns, albeit not yet reaching previous highs. Capital utilization follows a similar pattern of efficiency peaking early in the period before reducing and then slightly recovering. Overall, these trends reflect fluctuations in profitability and operational efficiency, with tax impacts playing a significant role in cash flow considerations.


Operating Profit Margin (OPM)

Intuitive Surgical Inc., OPM calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data (US$ in thousands)
Net operating profit after taxes (NOPAT)1
Add: Cash operating taxes2
Net operating profit before taxes (NOPBT)
 
Revenue
Add: Increase (decrease) in deferred revenue
Adjusted revenue
Profitability Ratio
OPM3
Benchmarks
OPM, Competitors4
Abbott Laboratories
CVS Health Corp.
Elevance Health Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 NOPAT. See details »

2 Cash operating taxes. See details »

3 2024 Calculation
OPM = 100 × NOPBT ÷ Adjusted revenue
= 100 × ÷ =

4 Click competitor name to see calculations.


Net operating profit before taxes (NOPBT)
The NOPBT shows an overall upward trend with fluctuations across the five-year period. It started at 1,231,357 thousand US dollars in 2020, increased significantly to 1,926,675 thousand in 2021, then declined to 1,636,114 thousand in 2022. Following that, it rose again to 2,019,953 thousand in 2023 and reached its highest point of 2,715,124 thousand in 2024. This pattern indicates a generally positive growth trajectory, despite a dip in 2022.
Adjusted revenue
The adjusted revenue consistently increased every year from 4,375,500 thousand US dollars in 2020 to 8,383,300 thousand in 2024. The growth appeared steady and strong, with no declines or plateaus noted. This continuous increase suggests successful sales expansion and market penetration over the period analyzed.
Operating profit margin (OPM)
The operating profit margin displayed variability, beginning at 28.14% in 2020, rising to a peak of 33.56% in 2021, then falling to a low of 26.19% in 2022. It recovered somewhat to 28.14% in 2023 and further improved to 32.39% in 2024. Although the margin experienced fluctuations, it remained above 25% throughout, indicating relatively strong operational efficiency with tendencies for improvement after dips.

Turnover of Capital (TO)

Intuitive Surgical Inc., TO calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data (US$ in thousands)
Revenue
Add: Increase (decrease) in deferred revenue
Adjusted revenue
 
Invested capital1
Efficiency Ratio
TO2
Benchmarks
TO, Competitors3
Abbott Laboratories
CVS Health Corp.
Elevance Health Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 Invested capital. See details »

2 2024 Calculation
TO = Adjusted revenue ÷ Invested capital
= ÷ =

3 Click competitor name to see calculations.


The financial data over the five-year period displays a generally positive trajectory in key performance indicators, signaling growth and some fluctuations in operational efficiency.

Adjusted Revenue
The adjusted revenue shows a continuous upward trend from 2020 to 2024. Starting at $4,375,500 thousand in 2020, revenue increased each year, reaching $8,383,300 thousand in 2024. This represents a substantial increase of approximately 91.6% over the five-year period, indicating robust sales growth and an expanding market presence.
Invested Capital
Invested capital also exhibits a rising trend over the years. Beginning at $4,486,200 thousand in 2020, it saw moderate growth in 2021 before increasing more significantly in subsequent years to reach $7,798,800 thousand in 2024. This reflects increased capital investment, potentially in assets or operational capacity, with a total growth of about 73.8% from 2020 to 2024.
Turnover of Capital (TO)
Turnover of capital, which measures the efficiency in using invested capital to generate revenue, shows variability over the period. It rose from 0.98 in 2020 to a peak of 1.27 in 2021, suggesting improved capital utilization efficiency during that year. However, it declined to 1.16 in 2022 and continued to decrease to 1.00 in 2023, before slightly improving to 1.07 in 2024. Despite the fluctuations, the turnover ratio remains close to 1, indicating relatively stable efficiency in capital usage overall, albeit with some volatility.

In summary, the company demonstrated strong revenue growth supported by increased invested capital, while the efficiency of capital usage experienced some fluctuations without a clear long-term trend of improvement or decline. Monitoring turnover of capital could help identify opportunities for enhancing operational efficiency as the company continues to expand its investment base.


Effective Cash Tax Rate (CTR)

Intuitive Surgical Inc., CTR calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data (US$ in thousands)
Net operating profit after taxes (NOPAT)1
Add: Cash operating taxes2
Net operating profit before taxes (NOPBT)
Tax Rate
CTR3
Benchmarks
CTR, Competitors4
Abbott Laboratories
CVS Health Corp.
Elevance Health Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 NOPAT. See details »

2 Cash operating taxes. See details »

3 2024 Calculation
CTR = 100 × Cash operating taxes ÷ NOPBT
= 100 × ÷ =

4 Click competitor name to see calculations.


Cash Operating Taxes
The cash operating taxes exhibited a significant upward trend over the five-year period. Starting at $82,150 thousand in 2020, the figure surged to $226,657 thousand in 2021, nearly tripling. This growth continued, reaching $448,291 thousand in 2022. Although there was a slight decrease in 2023 to $423,020 thousand, the value rebounded to $472,970 thousand in 2024, indicating overall strong growth in cash operating taxes paid.
Net Operating Profit Before Taxes (NOPBT)
The net operating profit before taxes showed considerable fluctuations but generally increased over the timeframe. It rose from $1,231,357 thousand in 2020 to $1,926,675 thousand in 2021, illustrating solid profitability growth. A decline occurred in 2022, with NOPBT dropping to $1,636,114 thousand. This was followed by a robust recovery and growth in the subsequent years, reaching $2,019,953 thousand in 2023 and $2,715,124 thousand in 2024, the highest value in the period.
Effective Cash Tax Rate (CTR)
The effective cash tax rate demonstrated notable volatility. Starting at a relatively low 6.67% in 2020, it nearly doubled to 11.76% in 2021. The tax rate then sharply increased to 27.4% in 2022, representing the peak over the analyzed years. Subsequently, the rate declined to 20.94% in 2023 and further to 17.42% in 2024. Despite the decrease after 2022, the rate remains substantially higher than the initial years, indicating changes in taxation or tax planning strategies impacting the company.
Overall Insights
Overall, the company’s profitability before taxes increased substantially over the five years, despite a temporary dip in 2022. The growth in cash operating taxes aligns broadly with the increases in profitability, although the tax burden, as reflected by the effective cash tax rate, showed considerable variation, peaking notably in 2022 before decreasing but remaining elevated relative to the earlier years. The observed patterns suggest dynamic operational performance combined with changing tax conditions or strategies through the period.